Francisco Jose Pais Brincheiro Md is categorized under Doctors in Reading, MA and active since 2011.
Francisco Jose Pais Brincheiro Md was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact F Jose Pais Brincheiro at the company’s single location by writing to 30 New Crossing Road # 301, Reading, Massachusetts MA 01867 or by phoning (781) 942-0380. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Francisco Jose Pais Brincheiro Md |
| Contact Person: | F Jose Pais Brincheiro |
| Address: | 30 New Crossing Road # 301, Reading, Massachusetts 01867 |
| Phone Number: | (781) 942-0380 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Francisco Jose Pais Brincheiro Md was started in 2011 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact F Jose Pais Brincheiro for inquiries that concern Francisco Jose Pais Brincheiro Md by calling the company number (781) 942-0380, as your correspondence is most welcome. Additionally, the physical location of the single location of Francisco Jose Pais Brincheiro Md can be found at the coordinates 42.518418,-71.095957 as well as the street address 30 New Crossing Road # 301 in Reading, Massachusetts 01867.
For its online presence, you may visit Francisco Jose Pais Brincheiro Md’s website at and engage with its social media outlets through on Twitter and on Facebook.